Evidence map›Paper›PMID 29885625›Full record

ArticleRedox biology2018

Cardiac-specific overexpression of aldehyde dehydrogenase 2 exacerbates cardiac remodeling in response to pressure overload.

Sujith Dassanayaka, Yuting Zheng, Andrew A Gibb, Timothy D Cummins, Lindsey A McNally, Kenneth R Brittian, Ganapathy Jagatheesan, Timothy N Audam, Bethany W Long, Robert E Brainard and 2 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction.Matrix biology : journal of the International Society for Matrix Biology · 2024
    Article
  2. Article
  3. Article
  4. Chronic Benzene Exposure Aggravates Pressure Overload-Induced Cardiac Dysfunction.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  5. Cardiac PANK1 deletion exacerbates ventricular dysfunction during pressure overload.American journal of physiology. Heart and circulatory physiology · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Sujith DassanayakaInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Yuting ZhengInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Andrew A GibbInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Timothy D CumminsDivision of Nephrology and Hypertension, Department of Medicine, University of Louisville, Louisville, KY, United States.
Lindsey A McNallyInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Kenneth R BrittianInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Ganapathy JagatheesanInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Timothy N AudamInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Bethany W LongInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Robert E BrainardDepartment of Physiology, University of Louisville, Louisville, KY, United States.
Steven P JonesInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States.
Bradford G HillInstitute of Molecular Cardiology, University of Louisville, Louisville, KY, United States; Diabetes and Obesity Center, Division of Cardiovascular Medicine, University of Louisville, Louisville, KY, United States. Electronic address: bradford.hill@louisville.edu.
University of Louisville · US

Funding

Tumor Necrosis Factor Modulation of CPCsP01HL078825 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2005 to 2021
$37.6M
Project 5 - Metabolomic Analysis of AtherothrombosisP20GM103492 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DEFILIPPIS, ANDREW · 2012 to 2017
$13.8M
TBDP30GM127607 · NIGMS · UNIVERSITY OF LOUISVILLE · PI HILL, BRADFORD GUY · 2018 to 2022
$6.3M
Regulation of Metabolic Genes in the HeartR01HL131647 · NHLBI · UNIVERSITY OF LOUISVILLE · PI JONES, STEVEN P · 2016 to 2019
$2.2M
Metabolic optimization of cell therapyR01HL130174 · NHLBI · UNIVERSITY OF LOUISVILLE · PI HILL, BRADFORD GUY · 2016 to 2020
$1.9M
Metabolic regulation of cardiac stem cellsR56HL122580 · NHLBI · UNIVERSITY OF LOUISVILLE · PI HILL, BRADFORD GUY · 2015 to 2015
$381k
NHLBI NIH HHS P01 HL078825NHLBI NIH HHS R01 HL130174NHLBI NIH HHS R01 HL131647NHLBI NIH HHS R56 HL122580NIGMS NIH HHS P20 GM103492NIGMS NIH HHS P30 GM127607
6 · The paper itself

Abstract

Pathological cardiac remodeling during heart failure is associated with higher levels of lipid peroxidation products and lower abundance of several aldehyde detoxification enzymes, including aldehyde dehydrogenase 2 (ALDH2). An emerging idea that could explain these findings concerns the role of electrophilic species in redox signaling, which may be important for adaptive responses to stress or injury. The purpose of this study was to determine whether genetically increasing ALDH2 activity affects pressure overload-induced cardiac dysfunction. Mice subjected to transverse aortic constriction (TAC) for 12 weeks developed myocardial hypertrophy and cardiac dysfunction, which were associated with diminished ALDH2 expression and activity. Cardiac-specific expression of the human ALDH2 gene in mice augmented myocardial ALDH2 activity but did not improve cardiac function in response to pressure overload. After 12 weeks of TAC, ALDH2 transgenic mice had larger hearts than their wild-type littermates and lower capillary density. These findings show that overexpression of ALDH2 augments the hypertrophic response to pressure overload and imply that downregulation of ALDH2 may be an adaptive response to certain forms of cardiac pathology.

Indexed as

Aldehyde Dehydrogenase, MitochondrialAnimalsAortaGene Expression RegulationHeart FailureHumansMiceMice, TransgenicMitochondriaMyocardiumOxidation-ReductionOxidative StressPressureSignal TransductionVentricular RemodelingAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanAldehydesCardiac remodelingHeart failureHormesisHypertrophyOxidative stress

Identifiers

PMID29885625
PMCPMC5991908
OpenAlexW2806120329

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.